Literature DB >> 11427281

Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen.

A H Noormohammadi1, H Hochrein, J M Curtis, T M Baldwin, E Handman.   

Abstract

Protective immunity against Leishmania major requires parasite-specific CD4+T helper cells, the development of which is promoted by interleukin 12 (IL-12). In this study we investigated the use of IL-12 DNA to enhance the protective immunity induced by prophylactic vaccination with the L. major Parasite Surface Antigen 2 (PSA-2) DNA. A plasmid was constructed in which the two murine IL-12 subunits p35 and p40 were secreted as a biologically active single chain cytokine. The immunomodulatory effects of this IL-12 DNA were examined by codelivery with PSA-2 DNA in susceptible BALB/c and resistant C3H/He mice and subsequent infection with L. major promastigotes. Surprisingly, administration of IL-12 DNA alone had a protective effect, while coadministration of IL-12 with PSA-2 DNA abrogated protection. This effect of IL-12 DNA was dose dependent and affected by the timing of administration in relation to PSA-2 DNA. The effect of IL-12 on protection was associated with a reduced number of INF-gamma-producing T cells early in infection. A further understanding of this paradoxical effect of IL-12 and possibly other cytokines on protective immunity may be important for their use as adjuvants for Leishmania DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427281     DOI: 10.1016/s0264-410x(01)00132-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major.

Authors:  Willy K Tonui; J Santiago Mejia; Lisa Hochberg; M Lamine Mbow; Jeffrey R Ryan; Adeline S T Chan; Samuel K Martin; Richard G Titus
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis.

Authors:  Kimberly Campbell; Hong Diao; Jiaxiang Ji; Lynn Soong
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.

Authors:  De-Wei Du; Zhan-Sheng Jia; Guang-Yu Li; Yong-Ying Zhou
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 4.  Leishmaniasis in humans: drug or vaccine therapy?

Authors:  Masoud Ghorbani; Ramin Farhoudi
Journal:  Drug Des Devel Ther       Date:  2017-12-22       Impact factor: 4.162

5.  Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection.

Authors:  Emmalene J. Bartlett; Vanessa S. Cull; Eva N. Mowe; Josephine P. Mansfield; Cassandra M. James
Journal:  Biol Proced Online       Date:  2003-02-17       Impact factor: 3.244

6.  Vaccination in Leishmaniasis: A Review Article.

Authors:  Latifeh Abdellahi; Fariba Iraji; Anahita Mahmoudabadi; Seyed Hossein Hejazi
Journal:  Iran Biomed J       Date:  2022-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.